Change over period: —
NSE · INSECTICID
INSECTCID
-28.8% from the 52-week high · +6.4% above the low
Insecticides (India) Ltd. is engaged in the manufacture and distribution of agro-chemicals comprising of technical and formulation. The company is headquartered in Delhi, Delhi and currently employs 1,472 full-time employees. The company went IPO on 2007-05-26. The firm is engaged in the manufacturing activities of agro chemicals, pesticides and technical products for agriculture purposes. The company operates through Agro Chemicals segment. Its product categories include insecticides, herbicides, fungicides, biologicals/plant growth regulators (PGR), and maharatna products. Its insecticides products include Lethal Gold, Mihir, Rockstar, Arrow, Bravo 5000, Indan 4G, Indan SP, Lethal Super 505, Logo, Monocil, Aikido, Phentom, Sargent, and Sharp. Its herbicides products include Super Racer, Master Stroke, Hakama Super, Hijack, Racer, Selector and Omega. Its fungicides products include Avone Plus, Care, Force 11, Pulsor, Focus, Navi and Himil. Its PGR products include Milstim Max, Kayakalp Pro, Surya Zinc, Myco Raja and Agro Spred Max. The firm's products are available in over 105 formulations and approximately 21 technicals. The company caters to both domestic and international markets.
The short version. INSECTCID reported revenue of ₹686 crore for Sep 2026, up 7.5% from a year earlier. Net profit was ₹56 crore (down 5.1% year on year). Return on equity was 11.4% in Mar 2026. Promoter holding was 72.3% in Sep 2026, up 0.00 points over 8 quarters.
1 · The price
How has the stock traded?
INSECTCID trades 28.8% below its 52-week high and 6.4% above its 52-week low.
2 · The business
Is it growing?
Sep 2026 revenue of ₹686 cr.
Sep 2026 net profit of ₹56 cr.
1.1 pts lower than a year earlier.
Revenue compounded at 6.1% over the same 3 years.
Reported results · ₹ crore
Revenue and profit
Show the numbers
Quarterly
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 686 | 612 | 426 | 385 | 638 | 691 | 359 | 358 |
| Net profit | 56 | 44 | 12 | 10 | 59 | 58 | 14 | 17 |
| Net margin % | 8.2 | 7.2 | 2.7 | 2.7 | 9.3 | 8.4 | 3.9 | 4.9 |
| EPS (₹) | 19.3 | 15.08 | 4.02 | 3.6 | 20.31 | 19.97 | 4.77 | 5.97 |
Annual
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2140 | 2000 | 1966 | 1801 | 1504 | 1420 | 1363 | 1192 |
| Net profit | 139 | 142 | 102 | 63 | 107 | 94 | 87 | 123 |
| Net margin % | 6.5 | 7.1 | 5.2 | 3.5 | 7.1 | 6.6 | 6.4 | 10.3 |
| EPS (₹) | 47.91 | 48.81 | 34.59 | 21.36 | 36.3 | 30.29 | 28.03 | 39.62 |
3 · The quality
How well does it turn capital into profit?
Return on equity was 11.4% in Mar 2026; debt to equity is 0.12.
Profitability · 4 years
Returns and margins
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | |
|---|---|---|---|---|
| Return on equity % | 11.4 | 13.1 | 10.1 | 6.9 |
| Return on capital % | 16.1 | 17.8 | 13.5 | 10.4 |
| EBITDA margin % | 11.1 | 11.4 | 8.7 | 6.8 |
| Net margin % | 6.5 | 7.1 | 5.2 | 3.5 |
Compound growth
Revenue vs profit
| 3 years | 5 years | |
|---|---|---|
| Revenue CAGR | 6.1% | 8.6% |
| Profit CAGR | 30.2% | 8.2% |
4 · The owners
Who holds it, and are they adding?
Unchanged over 8 quarters.
Down 0.69 pts over 8 quarters.
Up 0.02 pts over 8 quarters.
+1 versus the previous month.
Shareholding pattern (%)
Quarter by quarter
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Change | |
|---|---|---|---|---|---|---|---|---|---|
| Promoter | 72.3 | 72.3 | 72.3 | 72.3 | 72.3 | 72.3 | 72.3 | 72.3 | 0.0 |
| FII | 5.13 | 4.49 | 4.66 | 4.51 | 4.46 | 4.5 | 4.4 | 4.44 | -0.69 |
| DII | 9.24 | 9.59 | 9.72 | 9.5 | 9.4 | 9.27 | 9.26 | 9.26 | +0.02 |
| Public | 13.34 | 13.62 | 13.32 | 13.69 | 13.85 | 13.94 | 14.04 | 14.0 | +0.66 |
Mutual fund holdings · Oct 2026
1 scheme hold this stock
0 the month before.
- HDFC Small Cap Fund0.35% of NAV
5 · The model view
What does our factor model say?
Factor scores, model flags and screen results for INSECTCID are part of the Wright portfolio review.
Run your free portfolio reviewWatchouts
What to review
Model flags are shown inside the portfolio review, alongside your other holdings.
Related stocks
Other Fertilizers & Agrochemicals stocks
Quick answers
Common questions about INSECTCID
What is the INSECTCID share price?
INSECTCID (INSECTICID) last closed at ₹539.95, down 0.94% on the day. Its 52-week range is ₹512.45 to ₹765.10.
What is the market cap of INSECTCID?
INSECTCID has a market capitalisation of about ₹1,585 crore. Its price-to-earnings ratio is 13.1.
How are INSECTCID's latest results?
INSECTCID reported revenue of ₹686 crore for Sep 2026, up 7.5% from a year earlier. Net profit was ₹56 crore (down 5.1% year on year). Return on equity was 11.4% in Mar 2026. Promoter holding was 72.3% in Sep 2026, up 0.00 points over 8 quarters.
Who owns INSECTCID?
As of Sep 2026, shareholding was: Promoter 72.3%, FII 4.44%, DII 9.26%, Public 14.0%.
How many mutual funds hold INSECTCID?
1 mutual fund schemes held INSECTCID in October 2026. That compares with 0 the month before.
Corporate actions
Recent dividends, bonuses and splits
- 06 Feb 2026 · Interim Dividend - Rs. 2
- 23 Aug 2024 · Interim Dividend - Rs. 2
- 10 Nov 2023 · Interim Dividend - Rs. 3
- 24 Feb 2023 · Interim Dividend - Rs. 3
- 30 Sep 2022 · Bonus issue 1:2
- 15 Sep 2022 · Final Dividend - Rs. 3
Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.
Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.